Skeletal muscle abnormalities in pulmonary arterial hypertension

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Breda, Ana Paula ^a   Pereira De Albuquerque, Andre Luis ^a   Jardim, Carlos ^a   Morinaga, Luciana Kato ^a   Suesada, Milena Mako ^a   Fernandes, Caio Julio Cesar ^a   Dias, Bruno ^a   Lourenҫo, Rafael Burgomeister ^a   Salge, Joao Marcos ^a   Souza, Rogerio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BIOPSY; BODY COMPOSITION; CASE CONTROL STUDY; EXERCISE TOLERANCE; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; QUALITY OF LIFE; SKELETAL MUSCLE;

ADULT; BIOPSY; BODY COMPOSITION; CASE-CONTROL STUDIES; EXERCISE TOLERANCE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; QUALITY OF LIFE;

EID: 84914156225     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114101     Document Type: Article

References (39)

1. Hassoun PM, Mouthon L, Barbera JA, Eddahibi S, Flores SC, et al. (2009) Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 54: S10-19.
2. Humbert M, Sitbon O, Simonneau G (2004) Treatment of pulmonary arterial hypertension. N Engl J Med 351: 1425-1436.
3. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, et al. (2010) Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 122: 156-163.
4. Humbert M, Sitbon O, Yaici A, Montani D, O'Callaghan DS, et al. (2010) Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 36: 549-555.
5. Provencher S, Souza R (2010) Predicting survival in pulmonary arterial hypertension: time to move forward. Eur Respir J 35: 958-959.
6. Jardim C, Hoette S, Souza R (2010) Contemporary issues in pulmonary hypertension. Eur Respir Rev 19: 266-271.
7. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, et al. (2009) Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54: S55-66.
8. Mainguy V, Maltais F, Saey D, Gagnon P, Martel S, et al. (2010) Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax 65: 113-117.
9. Meyer FJ, Lossnitzer D, Kristen AV, Schoene AM, Kubler W, et al. (2005) Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension. Eur Respir J 25: 125-130.
10. Bauer R, Dehnert C, Schoene P, Filusch A, Bartsch P, et al. (2007) Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. Respir Med 101: 2366-2369.
11. Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, et al. (2006) Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation 114: 1482-1489.
12. Mainguy V, Maltais F, Saey D, Gagnon P, Martel S, et al. (2010) Effects of a rehabilitation program on skeletal muscle function in idiopathic pulmonary arterial hypertension. J Cardiopulm Rehabil Prev 30: 319-323.
13. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, et al. (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J.
14. dos Santos Fernandes CJ, Jardim CV, Hovnanian A, Hoette S, Dias BA, et al. (2010) Survival in schistosomiasis-associated pulmonary arterial hypertension. J Am Coll Cardiol 56: 715-720.
15. Lapa M, Dias B, Jardim C, Fernandes CJ, Dourado PM, et al. (2009) Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation 119: 1518-1523.
16. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473-483.
17. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. (2005) Standardisation of spirometry. Eur Respir J 26: 319-338.
18. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, et al. (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26: 511-522.
19. CAC Pereira SB, JG Simoes, FWL Pereira, JG Gerstler, J Nakatani (1992) Spirometric reference values for a sample of Brazilian adult population. Brazilian Journal of Pulmonology 18: 10-22.
20. Neder JA, Andreoni S, Castelo-Filho A, Nery LE (1999) Reference values for lung function tests. I. Static volumes. Braz J Med Biol Res 32: 703-717.
21. Neder JA, Andreoni S, Peres C, LE N (1999) Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfor factor). Braz J Med Biol Res 32: 729-737.
22. American Thoracic Society, European Respiratory Society (2002) ATS/ERS Statement on Respiratory Muscle Testing. Am J Respir Crit Care Med 166.
23. (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166: 111-117.
24. Neder JA, Nery LE, Castelo A, Andreoni S, Lerario MC, et al. (1999) Prediction of metabolic and cardiopulmonary responses to maximum cycle ergometry: a randomised study. Eur Respir J 14: 1304-1313.
25. Satta A, Migliori GB, Spanevello A, Neri M, Bottinelli R, et al. (1997) Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 10: 2853-2860.
26. Batt J, Ahmed SS, Correa J, Bain A, Granton J (2014) Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol 50: 74-86.
27. Debigare R, Marquis K, Cote CH, Tremblay RR, Michaud A, et al. (2003) Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 124: 83-89.
28. Lerario MC, Sachs A, Lazaretti-Castro M, Saraiva LG, Jardim JR (2006) Body composition in patients with chronic obstructive pulmonary disease: which method to use in clinical practice? Br J Nutr 96: 86-92.
29. Uszko-Lencer NH, Bothmer F, van Pol PE, Schols AM (2006) Measuring body composition in chronic heart failure: a comparison of methods. Eur J Heart Fail 8: 208-214.
30. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF (2005) Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 82: 53-59.
31. Futter JE, Cleland JG, Clark AL (2011) Body mass indices and outcome in patients with chronic heart failure. Eur J Heart Fail 13: 207-213.
32. Meyer FJ, Borst MM, Zugck C, Kirschke A, Schellberg D, et al. (2001) Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation 103: 2153-2158.
33. Dall'Ago P, Chiappa GR, Guths H, Stein R, Ribeiro JP (2006) Inspiratory muscle training in patients with heart failure and inspiratory muscle weakness: a randomized trial. J Am Coll Cardiol 47: 757-763.
34. Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, et al. (2000) Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 161: 487-492.
35. Deboeck G, Niset G, Lamotte M, Vachiery JL, Naeije R (2004) Exercise testing in pulmonary arterial hypertension and in chronic heart failure. Eur Respir J 23: 747-751.
36. Sun XG, Hansen JE, Oudiz RJ, Wasserman K (2001) Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 104: 429-435.
37. Dorfmuller P, Perros F, Balabanian K, Humbert M (2003) Inflammation in pulmonary arterial hypertension. Eur Respir J 22: 358-363.
38. Velez-Roa S, Ciarka A, Najem B, Vachiery JL, Naeije R, et al. (2004) Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation 110: 1308-1312.
39. Tolle J, Waxman A, Systrom D (2008) Impaired systemic oxygen extraction at maximum exercise in pulmonary hypertension. Med Sci Sports Exerc 40: 3-8.